Bone formation is a continuous process that begins during fetal development and persists throughout life as a remodeling process. In the event of injury, bones heal by generating new bone rather than scar tissue; thus, it can accurately be described as a regenerative process. To elucidate the extent to which fetal skeletal development and skeletal regeneration are similar, we performed a series of detailed expression analyses using a number of genes that regulate key stages of endochondral ossi®cation. They included genes in the indian hedgehog (ihh) and core binding factor 1 (cbfa1) pathways, and genes associated with extracellular matrix remodeling and vascular invasion including vascular endothelial growth factor (VEGF) and matrix metalloproteinase 13 (mmp13). Our analyses suggested that even at the earliest stages of mesenchymal cell condensation, chondrocyte (ihh, cbfa1 and collagen type II-positive) and perichondrial (gli1 and osteocalcin-positive) cell populations were already speci®ed. As chondrocytes matured, they continued to express cbfa1 and ihh whereas cbfa1, osteocalcin and gli1 persisted in presumptive periosteal cells. Later, VEGF and mmp13 transcripts were abundant in chondrocytes as they underwent hypertrophy and terminal differentiation. Based on these expression patterns and available genetic data, we propose a model where Ihh and Cbfa1, together with Gli1 and Osteocalcin participate in establishing reciprocal signal site of injury. The persistence of cbfa1 and ihh, and their targets osteocalcin and gli1, in the callus suggests comparable processes of chondrocyte maturation and speci®cation of a neo-perichondrium occur following injury. VEGF and mmp13 are expressed during the later stages of healing, coincident with the onset of vascularization of the callus and subsequent ossi®cation. Taken together, these data suggest the genetic mechanisms regulating fetal skeletogenesis also regulate adult skeletal regeneration, and point to important regulators of angiogenesis and ossi®cation in bone regeneration. q
Introduction
While traditionally we think of development in terms of events occurring between conception and birth, there is considerable reason to suspect that the same molecular and cellular mechanisms that regulate embryogenesis may also play a role in postnatal life. One such example is the process of skeletogenesis. Bone formation begins during early fetal development, continues throughout the life of an animal as skeletal remodeling and, if injury occurs, is reinitiated during the process of fracture repair. Unlike soft tissues, which heal predominantly through the generation of scar tissue, bones heal through the generation of new bone. Hence, bone repair can accurately be described as a regenerative process. Recent data suggest that the regenerative capacity of adult bone may depend upon the re-induction of the molecular pathways that mediate chondrogenesis and osteogenesis during fetal development (Sandberg et al., 1993; Iwasaki et al., 1997; Vortkamp et al., 1998) .
When there is motion at the site of injury, the primary mode of skeletal repair is through the formation of a cartilage scaffold, which is gradually replaced by bone. This type of healing closely recapitulates the steps involved in fetal endochondral ossi®cation. The ®rst overt step in endochondral ossi®cation is the aggregation of mesenchymal cells into discrete condensations that resemble the shape of the future skeletal element (Hall and Miyake, 1992) . A similar process occurs during the early stages of fracture repair (Hiltunen et al., 1993) . Mesenchymal cells populate the wound site, where they proliferate and then differentiate along a cartilaginous or an osteogenic lineage in response to growth factors and cytokines released by platelets, in¯ammatory cells, and neighboring cells and tissues (Bolander, 1992; Bruder et al., 1994) . Chondrocytes progress from a proliferative to a hypertrophic state during fetal development, in much the same way that they do during fracture healing. The majority of hypertrophic chon-drocytes are ultimately fated to undergo programmed cell death, which is accompanied by remodeling of the extracellular matrix and the subsequent deposition of new bone (for review see (Gerber et al., 1999a,b) Given the histological similarities between fetal skeletal development and adult fracture repair, the question remains open the extent to which the same molecular mechanisms govern the two processes.
To gain a better understanding of the similarities and differences between skeletal development and skeletal regeneration, we focused on molecular signals that were critical to one or both processes. Because the transcription factor core binding factor 1 (cbfa1) is essential for fetal osteogenesis (Komori et al., 1997; Otto et al., 1997) , our initial studies investigated whether cbfa1 participated in adult skeletal repair. Deletion of the cbfa1 gene results in a striking skeletal phenotype: homozygous null mutants (cbfa1 2/2 ) develop a normally patterned cartilage skeleton but there is almost a complete lack of endochondral and intramembranous ossi®cation (Komori et al., 1997; Mundlos et al., 1997; Otto et al., 1997) . It has been suggested that the cbfa1 mutant phenotype results from an arrest in osteoblast differentiation; this is based on the observation that cbfa1 is expressed in osteoblasts and directly regulates the expression of a number of osteoblast-related genes including osteocalcin (Ducy et al., 1997) . Supporting evidence comes from in vitro studies, which show that the over-expression of cbfa1 in ®broblasts induces these cells to express some osteoblast-related genes (Ducy et al., 1997) . The defective dermal bone formation in cbfa1 22 mice is also consistent with a role for cbfa1 in osteoblast differentiation (Komori et al., 1997; Otto et al., 1997) . We also analyzed the role of indian hedgehog (ihh) during skeletal formation and regeneration since ihh null mice show multiple defects in cell proliferation, chondrocyte maturation and osteogenesis (B. St. Jacques and A. McMahon, personal communication) . Ihh may exert its effects in part through the regulation of target genes such as the transcription factor gli1, and members of the bone morphogenetic protein (BMP) family (Vortkamp et al., 1996; Iwasaki et al., 1997; Pathi et al., 1999) .
The ®nal stages of endochondral ossi®cation depend upon the action of matrix metalloproteinases (MMPs), which degrade the cartilage matrix and allow the invasion of blood vessels (Vu et al., 1998) . At least two proteases are involved in this process; matrix metalloproteinase 13 (MMP13) which regulates remodeling of the hypertrophic cartilage matrix (Johansson et al., 1997) , and gelatinase B (MMP9), which has a role in vascularization of the growth plate (Vu et al., 1998) . A key angiogenic regulator during skeletal development is vascular endothelial growth factor (VEGF), which appears to be activated by MMP-mediated degradation of the cartilage matrix (Gerber et al., 1999a,b) . Therefore, our analyses included these markers of matrix degradation and vascularization as well.
Collectively, our data provide support for the hypothesis that certain aspects of skeletal regeneration, namely, cartilage maturation, vascular invasion and ossi®cation, are regulated by the same molecular signals. However, our studies also illustrate clear differences between fetal development and adult repair: notably, the mechanisms regulating mesenchymal cell condensation during development and the initial stages of fracture healing in adults appear to be distinct processes, with the role of in¯ammation being an important variable in adult healing. Understanding both the differences and similarities between fetal and adult programs for skeletogenesis will undoubtedly aid in the development of biologically based therapies designed to augment bone healing.
Materials and methods

Embryonic tissue collection
The forelimbs of mice at embryonic day 12 (e12), e13, e14.5 and e18, tibias from 10-week-old adult animals, were collected as described (Stern and Holland, 1993 ; Ruiz i Altaba, 1997).
Murine surgery
The model chosen for study was an unstable mouse tibia fracture, which heals with abundant cartilage formation (Bourque et al., 1992; Ashhurst, 1994; Le et al., 1997) All procedures strictly adhered to the protocols approved by the UCSF Committee on Animal Research. Adult 10±12-weekold Swiss Webster mice were given an intraperitoneal injection (0.015±0.017 ml/g body weight) of 2.5% Avertin (tribromoethanol; Fluka Chemie AG) to provide approximately 15±20 min of deep anesthesia. Closed diaphyseal fractures of the tibia were produced by three-point bending (Bonnarens and Einhorn, 1984) ; radiographs were taken immediately after fracture to con®rm the extent of injury. All mice (n 9) included in this part of the study were capable of weight bearing within 24 h, and were carefully monitored at frequent intervals for any signs of in¯amma-tion, discomfort or inability to ambulate. Mice were killed by cervical dislocation at 3, 6, 8, 10 and 14 days (n 9) after fracture.
Histological analysis
Tissues were collected, decalci®ed in buffered EDTA, dehydrated in a graded ethanol series, and embedded in paraf®n as described previously (Helms et al., 1994; Albrecht et al., 1997) . Five-mm sections were prepared and placed on TESPA-treated slides (3-aminopropyltriethoxy silane). Sections were stained with hematoxylin/ fast green/Safranin O.
In situ hybridization
Complementary DNAs corresponding to cbfa1, collagen type II (col2), collagen type X (col10), osteocalcin, indian hedgehog (ihh), bone morphogenic protein 6 (bmp6) and matrix metalloproteinase 13 (mmp13) were used to generate antisense 35 SUTP-labeled riboprobes as described (Albrecht et al., 1997) In situ hybridization was performed as described (Helms et al., 1996) . Slides were hybridized and washed at high stringency (598C, 1±2 £ SSC/50% formamide for embryonic tissues, 53±558C, 1±2 £ SSC/50% formamide for adult tissues). Emulsion-dipped slides were exposed to beta emissions from the 35 SUTP-labeled riboprobes for an average of 6 days for embryonic tissues, and 12 days for adult tissues.
Image analysis
Images were captured using a digital camera. Silver grain density was visualized via dark®eld; the signal was collected as white light and pseudocolored to facilitate differentiation between the cDNAs using Adobe Photoshop software. Tissues were counter-stained with Hoechst nuclear dye to visualize tissue outline (appears as a blue image). Following this, the dark®eld (signal) and¯uorescent (Hoechst-stained) images were superimposed to facilitate identi®cation of cells expressing a particular gene. In some cases, hybridization signals from two cDNAs were superimposed on the same tissue outline to visualize overlapping or complementary expression patterns. This was only done when the two probes had been applied to sections that were no more than 5 mm apart.
Results
Cbfa1 expression during fetal skeletogenesis
The initiation of skeletogenesis begins with the transition of undifferentiated mesenchyme into condensed mesenchyme. In mice, condensation begins at approximately e12 in the upper appendicular skeleton. Since cartilage maturation proceeds from proximal to distal in the limb, a single section through the humerus, radius and ulna and digits contains chondrocytes at varying stages of differentiation. Simultaneous with the process of mesenchymal cell condensation, collagen type II (col2) expression demarcated the future shape of the entire forelimb skeleton (Fig. 1A) . At this same time, cbfa1 was limited to a small group of cells in the proximal humerus (Fig. 1A ). This cbfa1 domain overlapped with that of ihh and a downstream target of Hedgehog signaling, gli1 (Fig. 1A) .
By e13, the mesenchymal cell condensations become organized to resemble the shapes of the future skeletal elements (Fig. 1B) , whereas mesenchymal cells on the periphery of the condensations contribute to the future perichondrium. At this stage, col2 expression delineated presumptive chondrocytes from presumptive perichondrial cells in all of the forearm skeletal elements (Fig. 1B) . Cbfa1 was detected in chondrocytes within the humerus, radius and ulna, coincident with col2, but cbfa1 transcripts were not detected in the pre-chondrogenic cells in the digits. Cbfa1 was also expressed in cells of the presumptive perichondrium (Fig. 1B) . Osteocalcin, which can be directly regulated by Cbfa1 (Ducy et al., 1997) , was strongly expressed in a broad band of mesenchymal cells that surrounded the condensations; whether all of these cells later contribute to the perichondrium is unclear (Fig. 1B) . The expression of osteocalcin preceded any overt signs of mineralization or osteoid formation. Ihh expression was limited to chondrocytes of the humerus, ulna and mesenchymal cells in the digits. In all of these locations, the gli1 domain in the perichondrium (Fig. 1B) surrounded the ihh domain. These early reciprocal expression patterns of ihh and gli1, and cbfa1 and osteocalcin suggest that cells have committed to chondrogenic and perichondrogenic lineages even at these very early stages of skeletal development.
By e14.5, skeletal tissues in the mouse forelimb are composed entirely of cartilage. Cells in the central region are beginning to undergo hypertrophy, signaling the site where vascularization of the skeletal element will ®rst occur ( Fig. 1C ). Cbfa1 was detected in both the perichondrium and in the central region of the cartilaginous radius, ulna ( Fig. 1C ) and digits. The cbfa1 domain overlapped with that of ihh and col10 in the center of the radius and ulna, indicating that the cells were mature and hypertrophic chondrocytes (Fig. 1C) . Cbfa1 also coincided with osteocalcin in the perichondrial tissues (Fig. 1C) ; this expression preceded overt signs of a mineralized matrix.
By e18, the cartilage skeleton is vascularized and bone has started to form in the center of the skeletal elements of the upper extremity ( Fig. 2A) . Cbfa1 was abundantly expressed in the newly formed bone of the primary ossi®ca-tion center and, to a lesser extent, in the periosteum and perichondrium ( Fig. 2A) . Osteocalcin expression overlapped cbfa1 in these locations ( Fig. 2A) . In addition, osteocalcin transcripts extended into the perichondrium surrounding the resting chondrocytes ( Fig. 2A) . As noted previously, cbfa1, ihh, bmp6 and col10 were abundantly expressed in mature, early hypertrophic and hypertrophic chondrocytes ( Fig. 2A) .
Angiogenesis coordinates the conversion of cartilage to bone
The conversion of cartilage to bone requires a precise coordination between chondrocyte maturation, extracellular matrix remodeling and angiogenesis. Therefore, we closely examined these steps in skeletogenesis. At e18.0±18.25, the primary ossi®cation center of the radius is¯anked on either side by hypertrophic chondrocytes and more peripherally, by mature, proliferating and resting chondrocytes (Fig. 2B) . Mesenchymal cells on the periphery of the primary ossi®ca-tion center are¯attened and elongated, and subsets of them have differentiated into osteoblasts. In the program of endochondral ossi®cation, two important events occur in close succession: chondrocytes undergo terminal differentiation and blood vessels invade the cartilage anlagen. Cbfa1 was abundantly expressed in the perichondrium/periosteum, in hypertrophic chondrocytes and in the newly formed bone (Fig. 2B ). Cbfa1 regulates mmp13 (M.J.G. Jimenz, pers. comm.), and their expression domains overlapped in hypertrophic chondrocytes and the newly formed bone (Fig. 2B) . Since one function of MMP13 is to remodel the extracellular matrix, it is possible that the function of Cbfa1 in these cells is to regulate degradation the matrix in preparation for vascular invasion. Cbfa1 overlapped with osteocalcin in both the periosteum and in the primary ossi®cation center (Fig. 2B) , suggesting that these cells were committed to an osteoblast cell fate. Angiogenesis of the cartilage anlage is regulated in part by VEGF (Gerber et al., 1999a,b) , which was expressed in hypertrophic chondrocytes. Vegf-positive cells were detected adjacent to, but not overlapping with, osteocalcin-expressing cells. Higher magni®cation of the interface between bone and chondrocytes showed that cbfa1 overlapped with two of its targets, mmp13 and osteocalcin (Fig. 2C ) in terminally differentiated chondrocytes and in bone. MMPs may mediate VEGF activity; in the terminally differentiated chondrocytes mmp13 and vegf expression domains were coincident (Fig. 2C) . Both transcripts, however, were excluded from the periosteum/perichondrium (Fig. 2C) . (Sandell et al., 1994) . In a near-adjacent section, cbfa1 transcripts are detected in cells of the presumptive humerus (h). These same cells express ihh and gli1. In addition, gli1 transcripts are also detected in the posterior mesenchyme. (B) By e13, Safranin O/Fast Green staining indicates that mesenchymal cell condensations are beginning to generate a cartilaginous matrix (faint red staining) in the humerus (h), radius (r) and ulna (u); this matrix is absent from the digits. Maturation proceeds in a proximal to distal direction in the limb. Therefore, mature chondrocytes are located in the humerus whereas more immature cells are located in the digit region (d). Col2 is abundantly expressed in chondrocytes throughout the humerus, radius and ulna, and in the presumptive digits. In an adjacent section, cbfa1 is expressed in chondrocytes of the humerus, radius and ulna (asterisk). In addition, cbfa1 is abundantly expressed in the perichondrium (white arrows). Osteocalcin transcripts are detected throughout the mesenchyme of the limb. Note that at this stage of development, osteocalcin expression overlaps with cbfa1 in the perichondrium of the humerus (arrows) and in the chondrocytes of the radius and ulna (asterisk). Ihh and gli1 are expressed in reciprocal patterns: ihh transcripts are restricted to chondrocytes in the humerus, radius (out of the plane of section), ulna and digits whereas gli1 is expressed in the perichondrium of these elements. (C) By e14.5, mature (mc) and hypertrophic chondrocytes (hc) are arranged longitudinally in the radius and ulna, which is surrounded by a thickened perichondrium (p). No bone is visible at this stage of development. Col10 are detected in hypertrophic chondrocytes. In an adjacent section, cbfa1 is strongly expressed in the perichondrium and to a lesser extent, in hypertrophic chondrocytes. Osteocalcin is expressed in the perichondrium, coincident with cbfa1 expression in this tissue. At this stage, ihh is restricted to mature and early hypertrophic chondrocytes, where it overlaps slightly with cbfa1.
Gene expression in the postnatal skeleton
After birth, the skeleton continues to grow through both the apposition of new bone along the periosteal surfaces of long bones and through the replacement of cartilage at the primary growth plate. In 10 day-old (juvenile) mouse tibial growth plates, cbfa1 and osteocalcin transcripts were evident in the bony trabeculae of the primary growth plate (Fig. 2D) . Cbfa1 was also detected in hypertrophic chondrocytes in the secondary ossi®cation center, coincident with col10 (Fig. 2D, arrows) . In addition, low levels of cbfa1 and ihh were detected in mature and hypertrophic chondrocytes (Fig. 2D) . Transcripts of all of these genes were detected in the growth plates and secondary ossi®ca-tion centers of long bones (data not shown).
Cbfa1 and related genes are re-induced during adult bone repair
The embryonic expression patterns indicate that Cbfa1, Ihh and their target genes participated in both chondrogenic and osteogenic programs of skeletal development. Therefore, to address whether these genes also participate in the same processes in adult bone repair, we created fractures in skeletally mature mice and monitored fracture callus tissues throughout the stages of healing for the expression of these genes.
The initial phase of skeletal repair is characterized by an in¯ammatory reaction and, in response to growth factors and cytokines, the aggregation of mesenchymal cells in the fracture site (Fig. 3A) . By three days post-fracture, Fig. 2 . Gene expression during cartilage maturation, vascular invasion and ossi®cation. (A) By e18, bone formation begins in the forelimbs. Mature (mc) and hypertrophic chondrocytes (hc) border the primary ossi®cation center (b), which is evident within the center of the distal ulna. The periosteum (p) has formed a bony collar and the perichondrium is visible as a thickened epithelium adjacent to the mature chondrocytes. Cbfa1 is strongly expressed in the perichondrium and periosteum, in mature and hypertrophic chondrocytes, and in bone (b). On an adjacent section, osteocalcin is abundantly expressed in both the perichondrium and periosteum, and in the primary ossi®cation center. The ihh, bmp6 and col10 expression domains overlapped with cbfa1. (B) Nuclear Hoescht stain illustrates the cellular outline of the primary ossi®cation center at e18.25. Note that the periosteum (p) has formed around the periphery of the skeletal element; bone (b) is forming in the central region, surrounding on either side by hypertrophic chondrocytes (hc). Cbfa1 (yellow) and mmp13 (aqua) signals are superimposed to show the extent of overlap between the two transcripts in hypertrophic chondrocytes. Note the absence of mmp13 in the periosteum, where intramembranous ossi®cation is occurring. Cbfa1 (yellow signal) and osteocalcin (red) are co-expressed in areas of new bone formation including the periosteum and in the primary ossi®cation center. Vegf is strongly expressed in hypertrophic chondrocytes and weakly in bone, where it overlaps with osteocalcin. (C) Higher magni®cation shows that mmp13 transcripts are limited to the hypertrophic and terminally differentiated chondrocytes, similar to vegf. Cbfa1 is detected in chondrocytes, bone and periosteum, coincident with osteocalcin. (D) In the tibial growth plate of a 10-day old mouse, there is an orderly progression of chondrocytes from a proliferative (pc) to a hypertrophic state (hc). New bone formation is evident distal to the hypertrophic zone (b). In addition, the secondary ossi®cation center (28) is evident; the arrow indicates the location of hypertrophic chondrocytes in this center. At this stage, cbfa1 is weakly expressed in mature and hypertrophic chondrocytes in both the growth plate and secondary ossi®cation center. Cbfa1 is more strongly expressed in regions of new bone formation. Osteocalcin transcripts are detected throughout the trabecular bone of the growth plate. Ihh is restricted to mature and early hypertrophic chondrocytes of the growth plate, with very low levels detected in the secondary ossi®cation center. The col10 expression domain overlaps with that of cbfa1 in the secondary ossi®cation center (arrow) and to a lesser extent, in hypertrophic chondrocytes of the growth plate.
cbfa1, osteocalcin and col2 transcripts were detected in mesenchymal cells in the fracture hematoma (Fig. 3A) . During the intermediate stage of repair (approx. 6±10 days post-fracture), the soft callus is predominantly composed of cartilage, as indicted by Safranin O/Fast Green staining of the callus (Fig. 3B) . Col2 expression delineated these cell populations (Fig 3B) . Cbfa1 and ihh transcripts were detected in these same regions (Fig. 3B) . A small subpopulation of chondrocytes had undergone hypertrophy as indicated by col10 expression (Fig. 3B) . These hypertrophic chondrocytes also expressed vegf (Fig. 3B ). Higher magni®cation indicated that these vegf-positive cells were coincident with osteocalcin-expressing regions (Fig. 3B) .
During the hard callus phase of healing (approximately and ihh can be detected throughout the callus, and osteocalcin transcripts are seen in the newly formed woven bone. At 14 days post-fracture, extensive new bone formation is evident, with small islands of residual cartilage persisting. Cbfa1 is detected at low levels in areas of ossi®cation and within the cartilage islands, but is not detected in the periosteum. Osteocalcin is evident throughout areas of bone formation, but is excluded from the cartilage islands. Col2 shows a reciprocal expression pattern, being restricted to the small islands of cartilage in the callus.
ten to fourteen days post-fracture), the callus is composed primarily of hypertrophic cartilage and woven bone (Fig.  4A,B ). Cbfa1 overlapped with both col2 and ihh in chondrocytes, and osteocalcin in woven bone at both time points (Fig. 4A,B) . Although the callus is an amorphous tissue, it was clear that the majority of woven bone was found in the central region of the cartilage callus (Fig. 4B) and that vascularization appeared to proceed from the periphery of the callus towards the central region.
Discussion
Do similar molecular programs regulate skeletal development and regeneration?
Fetal skeletal development and adult skeletal repair share a number of common characteristics, yet obvious distinctions also exist between the two programs. For example, pluripotent mesenchymal stem cells consolidate and proliferate to yield the fetal skeleton. An equivalent cell population may exist in the adult (Pittenger et al., 1999) , but whether it contributes substantially to skeletal regeneration is unknown. The ability of stem cells to respond to growth factors and other environmental cues may change as the animal ages (e.g. Quarto et al., 1995) . Another important difference is the role of in¯ammation; whereas the in¯am-matory process does not participate in fetal skeletogenesis, in¯ammatory cells are a major source of osteo-inductive signals during healing (Probst and Spiegel, 1997) . Finally, there is growing evidence that hormones and other systemic factors participate in fracture repair, yet their contribution to fetal skeletal development remains questionable (Klaushofer and Peterlik, 1994) .
The purpose of this study was to determine the extent to which the molecular regulation of skeletogenesis is conserved during embryonic life and adulthood. In this study we used the spatiotemporal expression patterns of several genes to characterize speci®c stages of chondrogenesis and osteogenesis, and to understand how angiogenic factors may coordinate these differentiation pathways. We show here that, from a molecular perspective, the progression from an immature fracture callus to a bony callus bears a close resemblance to the stages of fetal endochondral ossi®cation. We speculate that the proteins encoded by these genes serve similar functions in the adult and in the fetus, and thus are viable targets for therapeutic interventions.
The stages of skeletal development and repair
The onset of skeletogenesis, whether during fetal development or adult repair, begins with the condensation of mesenchymal stem cells at sites where the bony skeleton forms (reviewed in (Hall and Miyake, 1995) ). The process of condensation involves the activation of transcription factors such as Hoxa4, Cart1, Cbfa1 and Sox9. These genes participate in de®ning the population of cells that contribute to the condensation. Growth factors, including those in the TGFb superfamily, induce mesenchymal and chondrocyte cell proliferation (reviewed in Mundlos and Olsen, 1997a,b) . Subsequently, structural proteins such as syndecan-3, tenascin and versican are produced by the condensed cells, leading to the establishment of the cartilage anlage (Koyama et al., 1995 (Koyama et al., , 1996 . Whether a process analogous to mesenchymal condensation occurs during the early stages of skeletal repair remains an open question. Certainly, mesenchymal cells aggregate at the site of the wound, but this is primarily in response to growth factors and cytokines that are produced by in¯ammatory cells (reviewed in (Simon, 1994) ). The source of these mesenchymal`stem' cells is uncertain; they may arise from the bone marrow (Brighton and Hunt, 1991; , from the periosteum near the site of injury (Caplan, 1987; Breitbart et al., 1998) or even from the surrounding soft tissues (Caplan, 1987) . Obturating the bone marrow cavity or removing the periosteum can delay healing of a fracture (Oni and Gregg, 1991; Oni et al., 1992; Stafford et al., 1992 Stafford et al., , 1994 , presumably by interfering with these potential sources of osteoprogenitor cells. However, neither procedure by itself is suf®cient to prevent fracture repair, suggesting that one osteoprogenitor source may be able to compensate for the loss of the other. Clearly, identifying the source(s) of skeletal precursor cells is of considerable importance when developing methods to augment or accelerate skeletal repair.
Shortly after the condensation stage, cells in the central region of the aggregation begin to adopt a cartilaginous phenotype . The sustained expression of col2 demarcates this event, followed shortly thereafter by the induction of cbfa1 and ihh in the same cells (Fig. 1) . The functions of Cbfa1 and Ihh at this early stage are unknown. Mice carrying null mutations in cbfa1 (Komori et al., 1997; Otto et al., 1997) and Ihh (B. St. Jacques, personal communication) both form normally positioned, albeit smaller, condensations, suggesting that the proteins are not essential for condensation and the initial commitment to a chondrogenic lineage. What is clear from analyses of the cbfa1 2/2 and ihh 2/2 null phenotypes is that the process of cartilage maturation is defective.
In addition to its role in chondrogenesis, Cbfa1 is required for intramembranous ossi®cation. This is demonstrated by the defect in the transition of perichondrium to periosteum. Perichondrial cells in the cbfa1 2/2 mutant are poorly organized, do not express osteocalcin nor differentiate into mature osteoblasts (Komori et al., 1997) . Cbfa1 null mice also exhibit a poorly organized ®brous tissue in the place of their dermal bones (Komori et al., 1997) .
Genetic and epigenetic in¯uences on bone healing
Both genetic and epigenetic factors ®gure predominantly in the healing of a fracture callus. Whereas the same mole-cular cues apparently mediate fetal and adult skeletogenesis, additional factors, such as the mechanical environment, clearly in¯uence healing in an adult animal. When there is excess motion at the site of injury the predominant mechanism of bone regeneration is through the formation of a cartilaginous callus, which is gradually replaced by bone (Figs. 3  and 4) . Conversely, when the bone segments are stabilized, healing occurs primarily through intramembranous ossi®ca-tion. Presumably the same population of mesenchymal cells reside at the wound site in both cases, so how is it that mesenchymal cells`sense' the mechanical environment and differentiate accordingly? A number of hypotheses have been made, ranging from the ability of cells to transmit mechanical signals to the cytoskeleton via mechanoreceptors (Wang et al., 1993) , to alterations in the pH resulting from micro-motion (Brighton and Hunt, 1997) We propose that the mechanical environment exerts its in¯uence on cell differentiation by affecting angiogenesis (Fig. 5) . In such a model, mesenchymal stem cells at the fracture site are capable of differentiating either into osteoblasts or chondrocytes and would express molecular markers of this state (e.g., cbfa1, sox9). The cell fate decision would be in¯uenced by growth or survival factors delivered via an intact vasculature, or by the vasculature acting as a conduit to deliver osteoblasts to the site. In the event of a disruption in the blood supply, an avascular tissue, cartilage, forms. As the cartilage scaffold stabilizes the bone segments, neovascularization can occur and osteoblasts can once again proliferate and differentiate, in effect replacing the cartilage callus (Fig. 5) .
Angiogenesis coordinates the conversion of cartilage to bone
Cbfa1 plays an essential role in coordinating the maturation of chondrocytes, the remodeling of the extracellular matrix and angiogenesis. Cbfa1 is required for chondrocyte maturation, perhaps through its regulation of osteocalcin and osteopontin. Although typically referred to as osteoblast-speci®c, these genes are abundantly expressed in hypertrophic and terminally differentiated chondrocytes (Nomura et al., 1989; Lian et al., 1993; Gerstenfeld and Shapiro, 1996) . One function of osteopontin is to mediate the attachment of cells to the extracellular matrix (Somerman et al., 1987; Reinholt et al., 1990; Miyauchi et al., 1991) . Therefore, Cbfa1 may indirectly affect chondrocyte terminal differentiation and apoptosis by affecting cellmatrix interactions. Second, Cbfa1 is essential for extracellular matrix remodeling. Cbfa1 directly regulates mmp13 and, in conjunction with existing data (Vu et al., 1998) , our model predicts that matrix metalloproteinase-mediated remodeling of the hypertrophic cartilage matrix is required for ossi®cation. Remodeling of the matrix may also be necessary in order to release functional VEGF from its extracellular stores, and thereby induce angiogenesis.
How does degradation of the extracellular matrix lead to angiogenesis? There are at least two possibilities. First, a physical removal of the extracellular matrix might be required in order to allow endothelial cell invasion. Second, the process of remodeling may release angiogenic factors from the extracellular matrix. One candidate molecule is VEGF. VEGF is abundantly expressed in hypertrophic chondrocytes as well as in the perichondrium, and gelatinase B mutant mice exhibit a defect in VEGF signaling and angiogenesis. In addition, gelatinase B expression precedes that of the VEGF receptor,¯k1, in hypertrophic chondrocytes (C. Colnot and J.A.H., unpublished data) . These data favor the second model, where remodeling of the cartilage matrix releases angiogenic factors that are essential for endothelial cell invasion and following that, ossi®cation.
In the ®nal stages of skeletal development, bone supplants the cartilage anlage. An analogous situation occurs during repair, when woven bone is deposited on the cartilage callus. A disruption in angiogenesis at this stage can produce a non-healing bone, which is typically referred to as a delayed union or non-union. Non-unions have traditionally been divided into two categories, depending upon the presence or absence of an intact blood supply. Hypertrophic non-unions, which form from in response to excess motion at the fracture site, are composed primarily of hypertrophic cartilage and are treated by stabilization of the bone segments. Conversely, atrophic non-unions most frequently form in areas of poor blood supply, such as the tibial diaphysis, and are composed of ®bro-cartilaginous tissue that fails to differentiate into bone. Based on our data, it is possible that hypertrophic non-unions represent an arrest in matrix metalloproteinase-mediated remodeling Fig. 5 . A proposed model suggesting how motion at the site of injury in¯uences skeletal tissue regeneration. After injury, excess motion at the fracture site may disrupt new blood vessel formation. In such a case, the formation of an avascular tissue, cartilage, is favored. When the cartilage callus provides suf®cient stabilization to the tissue, vascular invasion commences and the cartilage scaffold is replaced by bone. In a stable mechanical environment, new blood vessels may form immediately, thus delivering growth factors or cytokines that permit the direct differentiation of mesenchymal cells into osteoblasts. Alternatively, the new vasculature may be the conduit along which osteoblasts migrate to the site of injury.
of the extracellular matrix and/or a defect in VEGF function. Alternatively, atrophic non-unions may represent a defect in the proliferation or differentiation of mesenchymal cells to a cartilaginous or osseous lineage. We are currently focusing on how genetic perturbations in matrix metalloproteinases and angiogenic factors lead to non-unions in a mouse model.
